Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Wyeth To Set Up Asia’s Largest Milk Formula Factory In Suzhou

This article was originally published in PharmAsia News

Executive Summary

Wyeth has announced plans to build Asia's largest milk formula factory in Suzhou, China. It has received the National Development and Reform Commission's approval for the new plant occupying 12 hectare of land, targeted for completion by the end of 2010. With an initial output of 90 million pounds (about 40,000 tons) of high-quality baby milk powder formula, the plant is expected to have a maximum production capacity of up to 80,000 tons. Wyeth officials decline to reveal the investment amount but analysts estimate the total capital injection to be more than $250 million. Research firm IMS projects the milk formula market in China to reach $3 billion in 2010, with high-quality formula occupying half. (Click here for more - Chinese Language)

You may also be interested in...

Wyeth Builds Major New Facility In China

SHANGHAI - Wyeth will invest $280 million to build a state-of-the-art nutritional manufacturing facility in Jiangsu Province's Suzhou Industrial Park, the company announced March 10 during the foundation laying ceremony

Guardant Health Expects FDA Approval Of Liquid Biopsy Test Will Strengthen Coverage, Adoption

Guardant’s CEO anticipates accelerated adoption and reimbursement of its FDA-approved liquid biopsy assay and more biopharma partnerships.

Finance Watch: CureVac’s IPO Is Ready For Launch

Public Company Edition: The German mRNA-focused company could raise up to $245m based on its proposed price range, but investor interest could drive the offering’s total higher. Also, Perceptive launches another SPAC, Regeneron sells $2bn in debt and Biohaven secures up to $950m. 




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts